Publications des scientifiques de l'IRD

Pion Sébastien, Chesnais Cédric, Weil G. J., Louya F., Boussinesq Michel, Missamou F. (2022). Impact of semi-annual albendazole on lymphatic filariasis and soil-transmitted helminth infection : parasitological assessment after 14 rounds of community treatment. American Journal of Tropical Medicine and Hygiene, 106 (2), p. 729-731. ISSN 0002-9637.

Titre du document
Impact of semi-annual albendazole on lymphatic filariasis and soil-transmitted helminth infection : parasitological assessment after 14 rounds of community treatment
Année de publication
2022
Type de document
Article référencé dans le Web of Science WOS:000762022500034
Auteurs
Pion Sébastien, Chesnais Cédric, Weil G. J., Louya F., Boussinesq Michel, Missamou F.
Source
American Journal of Tropical Medicine and Hygiene, 2022, 106 (2), p. 729-731 ISSN 0002-9637
Between October 2012 and October 2015, we conducted a community trial to assess the impact of semi-annual (twice yearly) community treatment with albendazole on lymphatic filariasis in Seke Pembe, a village in the Republic of the Congo. Semi-annual community treatment with albendazole has been continued in the community since October 2015. We conducted an additional parasitological assessment survey in October 2019, 6 months after the 14th round of semi-annual treatment. Between October 2012 and October 2015, Wuchereria bancrofti antigenemia and microfilaremia rates in the community had decreased from 17.3% to 4.7% and from 5.3% to 0.3%, respectively. In October 2019, the antigenemia rate had decreased further to 2.8% (19 of 687). No microfilariae were found in night blood smears from persons with circulating filarial antigenemia (0 of 16), suggesting that W. bancrofti transmission has been interrupted in Seke Pembe. Semi-annual albendazole treatments also reduced significantly infection rates with soil transmitted helminths.
Plan de classement
Santé : généralités [050] ; Entomologie médicale / Parasitologie / Virologie [052]
Description Géographique
CONGO
Localisation
Fonds IRD [F B010084346]
Identifiant IRD
fdi:010084346
Contact